Treatment of Pulmonary Embolism in an Extremely Obese Patient

Authors: Diepstraten, Jeroen1; Kralingen, Simone2; Snijder, Repke3; Hackeng, Christian4; Ramshorst, Bert5; Knibbe, Catherijne6

Source: Obesity Surgery, Volume 19, Number 8, August 2009 , pp. 1186-1189(4)

Publisher: Springer

Purchase options

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.00 plus tax      Refund Policy

OR

 
More about this publication?
More like this?
Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial

Abstract:

Low-molecular-weight heparins are effective as initial therapy for pulmonary embolism (PE) in a weight-based dosing regimen up to known body weights of 160 kg. The present case reports an extremely obese man of 252 kg (body mass index (BMI) 74 kg/m2) with PE who was treated with tinzaparin, dosed on a body weight of 160 kg. Morbid obesity defined as a BMI higher than 40 kg/m2 is becoming more common in general practice, but there are no evidence-based drug dosing strategies for these patients. This case demonstrates the successful use of a maximum dose of 28,000 anti-Xa international units of tinzaparin for an extremely obese patient with proven PE, instead of the accepted doses of 175 IU/kg, as bridge therapy to a coumarin.

Keywords: Anti-Xa activity; Low-molecular-weight heparin; Morbid obesity; Pulmonary embolism; Tinzaparin

Document Type: Research article

DOI: 10.1007/s11695-009-9886-7

Affiliations: 1: Department of Clinical Pharmacy, St. Antonius Hospital, P.O. Box 2500, 3430 EM, Nieuwegein, The Netherlands 2: Department of Anaesthesiology, St. Antonius Hospital, Nieuwegein, The Netherlands 3: Department of Pulmonary Diseases, St. Antonius Hospital, Nieuwegein, The Netherlands 4: Department of Clinical Chemistry, St. Antonius Hospital, Nieuwegein, The Netherlands 5: Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands 6: Department of Clinical Pharmacy, St. Antonius Hospital, P.O. Box 2500, 3430 EM, Nieuwegein, The Netherlands, Email: c.knibbe@antoniusziekenhuis.nl

Back to top

Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in
Need to register?
Sign up here
Text size: A | A | A | A